BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang Z, Lin Y, Duan XW, Hang HY, Zhang X, Li LL. Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report. World J Clin Cases 2021; 9(13): 3090-3094 [PMID: 33969095 DOI: 10.12998/wjcc.v9.i13.3090]
URL: https://www.wjgnet.com/2307-8960/full/v9/i13/3090.htm
Number Citing Articles
1
Fengming Jia, Qing Zhao, Peidian Shi, Hong Liu, Furen Zhang. Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatosesDermatologic Therapy 2022; 35(12) doi: 10.1111/dth.15924
2
D. Darbord, G. Hickman, N. Pironon, C. Barbieux, M. Bonnet‐des‐Claustres, M. Titeux, S. Miskinyte, F. Cordoliani, M.D. Vignon‐Pennamen, R. Amode, A. Hovnanian, E. Bourrat. Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunityJournal of the European Academy of Dermatology and Venereology 2022; 36(1): 133 doi: 10.1111/jdv.17671